Investigation into ADMA Biologics
Block & Leviton is currently examining the activities of ADMA Biologics, Inc. (NASDAQ: ADMA) due to potential securities law violations that may impact numerous investors. This investigation emerged following a significant drop in ADMA's stock value, specifically after the company announced that its independent auditor would be resigning.
Impact on Share Prices
On the crucial date of October 10, shares of ADMA Biologics experienced a near 20% decline. This troubling news sent shockwaves through the investor community, prompting many to reassess their positions in the company. Understanding why such drops occur can help investors navigate similar situations in the future.
Eligibility for Participation
If you've purchased shares of ADMA Biologics and have encountered a decrease in value, you may be eligible to participate in this inquiry, regardless of whether you decided to sell your stocks. Such eligibility is essential for anyone who feels they have suffered financial loss due to circumstances surrounding this investigation.
The Role of Block & Leviton
Block & Leviton, a well-renowned firm in the field of securities law, is actively investigating whether ADMA Biologics has transgressed any securities regulations. They are prepared to file necessary actions that can assist those affected by these alleged violations, striving to recover lost investments for shareholders.
Next Steps for Investors
If you believe you have been adversely affected by the downturn in ADMA Biologics' stock prices, it is advisable to reach out to Block & Leviton. Their team is equipped to provide guidance on how to proceed, offering various options for investors looking to reclaim their losses. Options include direct contact via phone or email, where representatives are ready to assist and guide you through the process.
Whistleblower Opportunities
Individuals with knowledge of non-public information regarding ADMA Biologics are encouraged to consider contributing to the ongoing investigation. Participation in this context can involve a whistleblower report to the Securities Exchange Commission (SEC), which may lead to substantial rewards for the information provided.
Why Choose Block & Leviton?
Known for their impressive track record, Block & Leviton is regarded as a leading voice in the securities class action legal landscape. The firm has successfully recovered billions for investors who have been victims of fraud. Their dedicated team ensures that every client receives the diligence and representation necessary for a favorable outcome.
Frequently Asked Questions
What is the nature of the investigation into ADMA Biologics?
The investigation centers on potential violations of securities laws following significant drops in stock prices after the resignation of ADMA's independent auditor.
Who can participate in the investigation?
Anyone who purchased shares of ADMA Biologics and has experienced a decline in their investment may be eligible to participate.
What should I do if I believe I've incurred losses?
Contact Block & Leviton to understand your options for recovering losses. They provide various means of contact to assist investors promptly.
What can I expect from Block & Leviton?
Block & Leviton offers expertise in securities law and representation for investors seeking to recover financial losses. Their experienced team is dedicated to achieving the best outcomes for their clients.
How does the whistleblower program work?
The whistleblower program allows individuals with insider information to report to the SEC, potentially yielding rewards if their information leads to a successful recovery.
